Erratum to: Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial (Clin Res Cardiol, (2017), 106, (444–456), 10.1007/s00392-016-1074-x)

Gerasimos Filippatos, Dimitrios Farmakis, Marco Metra, Gad Cotter, Beth A. Davison, G. Michael Felker, Barry H. Greenberg, Tsushung A. Hua, Peter S. Pang, Piotr Ponikowski, Min Qian, Thomas A. Severin, Adriaan A. Voors, John R. Teerlink

Research output: Contribution to journalComment/debate

Abstract

The original article was published Online First without open access. After publication in volume 106, issue 6, pages 444–456 the author decided to opt for Open Choice and to make the article an open access publication. Therefore, the copyright of the article has been changed to

Original languageEnglish (US)
Number of pages1
JournalClinical Research in Cardiology
Volume106
Issue number11
DOIs
StatePublished - Nov 1 2017

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Filippatos, G., Farmakis, D., Metra, M., Cotter, G., Davison, B. A., Felker, G. M., Greenberg, B. H., Hua, T. A., Pang, P. S., Ponikowski, P., Qian, M., Severin, T. A., Voors, A. A., & Teerlink, J. R. (2017). Erratum to: Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial (Clin Res Cardiol, (2017), 106, (444–456), 10.1007/s00392-016-1074-x). Clinical Research in Cardiology, 106(11). https://doi.org/10.1007/s00392-017-1139-5